By 2020, chronic obstructive pulmonary disease (COPD) is projected to become the third leading cause of death worldwide . Every year, more than 3 million people worldwide die due to this chronic condition. Patients with COPD have a significantly shorter survival than comorbidity-matched controls . Most common causes of death in patients with COPD are non-respiratory, particularly cardiovascular diseases (myocardial infarction and stroke) and cancer . Previous exacerbations and hospitalisations, comorbidities, reduced lung function, and poor health status are the strongest predictors of death in patients with COPD . Although the treatment of symptoms and prevention of acute exacerbations has improved, few advances have been made to stop disease progression or prevent mortality. To reduce disease burden, smoking cessation, increasing physical activity, and early detection and treatment of comorbidities are essential. A global pol...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Introduction Next Article
Durvalumab after chemoradiotherapy extends OS in stage 3, unresectable non-small-cell lung cancer »
Table of Contents: ERS 2018
COPD: Triple therapy, MABA and antibiotics
Current look on asthma
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.